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   We have experienced 154 cases of the urinary bladder turnor for the past ten years， frorm
Jan． 1961 to Dec． ．197Q． 119 of 154 cases rece．i．ved sorr．］．e kind of treatrn．一eats fnvr the urinary’
bladder tumor． A follow－up study was also made as well as the statistical observation．
   1） The incidence of ur垣ary bladder tumor was 1．6％to the total number of new out－
patients and 5．7％ to inpatients．
   2） The total number of urinary bladder tumor was 154 with leO males and 54 females．
The male to female ratio was 1，87 ： 1．
   3） The・age distribution was as follows： 2 in the second decade， 2 in the third， 10 ’in the
fourth， 24 in the fifth， 32 in the sixth， 43 in the seventh， 36 in the eighth and 5 in the ninth．
   4）・ Treatments of 119 cases consisted of 11 total cystectorny， 23 partial cystectorny， 47
TUR and 38’other wavs．
   5） Histological patterns of the tumors consisted of 76 transitional cell types， 9 squamous／
cell carcinornas， 3 adenpcarcinomas， 2 leiomyQsarcomas， 1 basal cell carcinoma and 1 undifferen－
tiated carcinoma．
   6） The correlation of tumQr cell type and stage．was as follows： Many of transitional ．cell
type apd one case of undiffentiated carcinoina belonged to low stage group． All squamous cell
carcinomas， adenocarcinorpas， leiomyosarcomas and basal cell carcinoma belonged to high stage
group．
    7） The correlation of tumor cell type and． grade was as follows： Many of transitional
cell type belonged to grade 3 and all other turnors belonged to grade 4．
    8） Follow－up studies：
    （1） As for 5－year－survival rate after the various treatments， it was O％ in total cystec一・
tomy， 2Q．O％ in partial cystectomy and 60．OS｝．Er in TUR．
    （2） As for 5－year－survival rate by the histological classificatlon， it was 50．0％ in transi一
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tional cell type， O％ in squamous cell carcinoma and 33．3 ％ in adenocarcinoma．
  （3） As for 5－year－survival rate by the depth of infiltration， it was 87．5／dO in the low stage
group andユ2．9％in the high stage group．
  （4） 5－year－survival rate of al！ the cases was 39．3％．
  （5） Recurrence rate after TUR of high stage group was fewer than that of low stage
group．
  （6） As for 5－year－survivaユrate after TUR， it was 85．7％in low stage group and 27．3％
in high stage group． TUR was assumed to be the best urological treatrnent of choice in the
vast majority of the urinary bladder tumors， especially in the cases of low stage group．



















   性別および年令別頻度（Table 1）
 まず，性別についてみると，154月中，男子！00例，










Table 2． 治    療    法







































































































































行上皮型の76例では，stage O 5例， stage A 30例，
stage B， 12例， stage B214例， stage C 15例であっ
た．扁平上皮癌の9例では，stage B・以下のものがな
















腺     癌
平滑筋肉腫
基底細胞癌
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移行上皮型
扁平上皮癌
腺    癌
平滑筋肉腫
基底細胞癌


















Fig．1．膀胱腫瘍の浸潤度（H． J． Jewett） 計






























































 浸潤度は前述のごとく10w stageとhigh stageに
Table 5．治療と生存率










 無 治 療





































































移 行 上 皮 型
扁 平 上 皮 癌
腺       癌
平 滑 筋 肉 腫
基 底 細 胞 癌
未 分 化 癌
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Table 8． TUR Bt（40例）浸潤度と再発
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